Literature DB >> 18651407

Principles of simple heart rate adjustment of ST segment depression during exercise electrocardiography.

Paul Kligfield1.   

Abstract

Compared with standard test criteria, simple heart rate (HR) adjustment of ST depression during exercise electrocardiography can improve the identification and assessment of underlying coronary artery disease. Since heart rate during exercise drives progressive ST segment depression in the presence of coronary obstruction that limits flow reserve, the ST/HR index controls for the increasing metabolic severity of ischemia that accompanies exercise. Improvement of exercise test sensitivity with the ST/HR index results from reclassification of otherwise "equivocal" and even "negative" test responses, including increased identification of one and two-vessel disease in men and in women. In addition, in population studies of low and moderate risk subjects, the ST/HR index can increase the prognostic value of the exercise electrocardiogram for prediction of cardiac risk and mortality.

Entities:  

Mesh:

Year:  2008        PMID: 18651407

Source DB:  PubMed          Journal:  Cardiol J        ISSN: 1898-018X            Impact factor:   2.737


  4 in total

1.  The exercise ECG: still a useful exercise?

Authors:  E E van der Wall
Journal:  Neth Heart J       Date:  2009-02       Impact factor: 2.380

2.  Spatial organization of acute myocardial ischemia.

Authors:  Kedar Aras; Brett Burton; Darrell Swenson; Rob MacLeod
Journal:  J Electrocardiol       Date:  2016-02-20       Impact factor: 1.438

Review 3.  Application of exercise ECG stress test in the current high cost modern-era healthcare system.

Authors:  Gaurang Nandkishor Vaidya
Journal:  Indian Heart J       Date:  2017-06-17

4.  Interleukin-6 and activin A are independently associated with cardiovascular events and mortality in type 2 diabetes: the prospective Asker and Bærum Cardiovascular Diabetes (ABCD) cohort study.

Authors:  Anne Pernille Ofstad; Lars Gullestad; Elsa Orvik; Svend Aakhus; Knut Endresen; Thor Ueland; Pål Aukrust; Morten W Fagerland; Kåre I Birkeland; Odd Erik Johansen
Journal:  Cardiovasc Diabetol       Date:  2013-08-30       Impact factor: 9.951

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.